LISATA THERAPEUTICS, INC. — Director's Dealing 2011

Mar 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-02-28

Reporting Person: Smith Robin L (Director, Chairman of the Board and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-28	Common Stock, $0.001 par value	P	6136	$1.28	Acquired	978819	Direct

Footnotes

F1: Due to restrictions on Dr. Smith in purchasing common stock of NeoStem, Inc. (the "Company") in the open market and in
response to her desire to increase her ownership in the Company, on February 18, 2011, the Board of Directors approved her
request to receive her net salary for the period February 16, 2011 through May 15, 2011 through the issuance to her by the
Company of shares of its common stock at the then market price.